Leader'S Club은 유가증권 성장 법인과 코스닥 성장 법인을 대상으로 IR(Investor Relations)활동을 지원하는 서비스 입니다.
-
₩ 20,600
₩ -50
-
-
Previous Close
20,650
-
Open
20,650
-
High
20,900
-
Low
20,450
-
Volume
37,547
-
Market Cap (T KRW) Unit 1,000 won
337293424
-
Industry
pharmaceuticals and other healthcare pro
-
CEO
Kang Duk-young
-
Headquarters
154-8 Nonhyun-Dong, Kangnam-Ku, Seoul, Korea
-
Website
-
Korea holds line on chips as US tariff deal offers strategic relief
proposed US reciprocal tariffs on Korean imports from 25 percent to 15 percent. In return, Korea committed to launching a $350 billion investment fund to support US industries, including shipbuilding
-
Seoul, Washington strike $450b deal to cap US tariffs at 15%
Agreement features $350b investment package, $100b energy imports, most-favored-nation status in key sectors South Korea clinched a last-minute trade deal with the United States on Thursday, capping
-
Lee says S. Korea-US trade deal to help dispel trade uncertainties
President Lee Jae Myung said Thursday a tariff deal reached by South Korea and the United States will help eliminate economic uncertainties for the South's export-reliant economy, voicing relief for
-
Seoul shares extend winning streak to 6th day amid looming US tariff deadline
Korea and the United States, with just two days remaining until the Aug. 1 deadline for a deal before the US starts imposing reciprocal tariffs, including a 25 percent duty on South Korean imports. In the
-
GSK appoints industry veteran as head of Korean office
key roles at GSK Brazil, including vaccines business unit head and the biotech business unit head, as well as Global Vaccines Market Lead. GSK Korea noted that Riediger has consistently delivered
-
Seoul shares hit 4-yr high despite US tariff uncertainty
for a deal before the US starts imposing reciprocal tariffs, including a 25 percent duty for South Korea. The Kospi soon turned higher on the back of solid foreign buying and maintained the momentum
-
DCA Opens Today to Strengthen Asia's Data Centre Network
markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real
-
Scale Hits New High: HNC 2025 Concludes with Resounding Success, Driving a New Wave of Health Industry Upgrades
Korea, Japan, Malaysia, the United States, Canada, Singapore, Spain, Norway, etc. National pavilions and exhibitors from Italy, Spain, Slovenia, the United States, and Japan made their debuts in China at
-
SNB-101 Earns Government Backing as Promising Therapy for Small Cell Lung Cancer
selected as a clinical-stage project under the 2025 Korea Drug Development Project, a government-initiated program led by the Korea Drug Development Fund (KDDF). The program includes two years of research
-
LG Unveils Korea's First Open-weight Hybrid AI, 'EXAONE 4.0'
national professional qualifications, including doctor, dentist, herbal pharmacist, customs broker, appraiser, and Insurance adjuster. LG AI Research expects EXAONE 4.0 to provide highly accurate answers in